N/A
Completed N=20
Floseal Treatment for Posterior Epistaxis Study
Source: ClinicalTrials.gov NCT01098578 ↗Enrolled (actual)
20
Serious AEs
0.0%
Results posted
Jan 2015
Primary outcomePrimary: Effectiveness of Floseal for the Treatment of Posterior Epistaxis. — 20 participants
Summary
Effectiveness of Floseal for the treatment of posterior epistaxis.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Effectiveness of Floseal for the Treatment of Posterior Epistaxis. |
20 | — |
| SECONDARY Cost Savings of Floseal Treatment in Comparison to Posterior Packing, Surgical, and Embolisation Treatments for Posterior Epistaxis. |
45.40 | — |
Eligibility Criteria
Inclusion Criteria
- age greater than 18 years of age
- posterior epistaxis
Exclusion Criteria
- patients with anterior epistaxis
- known sensitivity to any of the materials of Floseal or the topical medications administered as part of the evaluation and treatment of epistaxis (lidocaine, xylometazoline hydrochloride)
- pregnant or breast feeding woman
Data sourced from ClinicalTrials.gov (NCT01098578). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.